Brochure | April 13, 2022

Build External Control Arms With De-Identified, Connected Real-World Data

Source: Datavant
GettyImages-1322205575 data ps

Many biopharma companies are seeking Datavant as their solution for ECAs for its end-to-end privacy and data connectivity technologies and ability to achieve high precision, research-grade matching.

1. Data quality and encryption

  • Armed with the study inclusion/exclusion criteria, each EHR vendor uses Datavant software to encrypt or “tokenize” the identifying information for the selected patient cohorts.

2. Identity resolution 

  • Tokenized datasets from each EHR are run through Datavant's machine learning matching model which identifies unique and duplicate patients without needing access to the underlying identifying information.

3. De identification and certification

  • End-to-end privacy-preserving record linkage is at the core of Datavant’s solution.

4. Distribution and linking

  • Once patients are accurately matched and assigned a DVID, Datavant provides the biopharma company EHR datasets with each record appended with the DVID as locally encrypted keys for security and privacy.

To learn more about Datavant, visit their Clinical Leader page.

VIEW THE BROCHURE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader